Advertisement

Topics

PellePharm's Topical Patidegib Nears Phase III For Gorlin Syndrome

12:44 EDT 1 Aug 2017 | SCRIP

Gel formulations of the hedgehog signalling inhibitor patidegib may be the long sought well-tolerated and effective therapy for basal cell...

       

Original Article: PellePharm's Topical Patidegib Nears Phase III For Gorlin Syndrome

NEXT ARTICLE

More From BioPortfolio on "PellePharm's Topical Patidegib Nears Phase III For Gorlin Syndrome"

Quick Search
Advertisement